This subpopulation of myeloid cells promotes neovascularization in tumor tissue by the expression of mediators such as vascular endothelial growth factor A (VEGF-A) or transforming growth factor beta (TGF-β) [44,45]. The gene discussed is TGFB1; the disease is neoplasm.